Transcat (NASDAQ:TRNS) Reaches New 1-Year Low - Should You Sell?

Transcat, Inc. (NASDAQ:TRNS - Get Free Report)'s stock price reached a new 52-week low on Monday . The stock traded as low as $70.47 and last traded at $72.47, with a volume of 64162 shares changing hands. The stock had previously closed at $74.84.

Analysts Set New Price Targets

TRNS has been the topic of several analyst reports. Craig Hallum increased their target price on Transcat from $113.00 to $125.00 and gave the company a "buy" rating in a research note on Thursday, December 12th. Oppenheimer lowered Transcat from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. HC Wainwright dropped their price target on Transcat from $126.00 to $106.00 and set a "buy" rating on the stock in a research report on Wednesday, January 29th. Northland Securities reaffirmed a "market perform" rating and set a $85.00 price target (down previously from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Finally, StockNews.com lowered Transcat from a "hold" rating to a "sell" rating in a research report on Wednesday, February 5th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $111.50.

Remove Ads

Transcat Stock Performance

The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14. The firm has a market capitalization of $670.81 million, a P/E ratio of 38.88 and a beta of 0.66. The stock has a fifty day moving average of $87.74 and a 200-day moving average of $105.14.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same quarter in the prior year, the firm earned $0.56 earnings per share. On average, research analysts anticipate that Transcat, Inc. will post 2.3 EPS for the current year.

Insider Buying and Selling at Transcat

In related news, Director Craig D. Cairns purchased 1,200 shares of the firm's stock in a transaction on Friday, January 31st. The stock was purchased at an average cost of $77.02 per share, for a total transaction of $92,424.00. Following the completion of the purchase, the director now directly owns 1,910 shares in the company, valued at $147,108.20. This trade represents a 169.01 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 2.30% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in TRNS. Jones Financial Companies Lllp boosted its stake in shares of Transcat by 686.7% during the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock worth $37,000 after acquiring an additional 309 shares during the period. Aquatic Capital Management LLC boosted its stake in shares of Transcat by 1,052.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock worth $122,000 after acquiring an additional 1,052 shares during the period. Morgan Dempsey Capital Management LLC bought a new position in shares of Transcat during the 4th quarter worth approximately $143,000. SG Americas Securities LLC bought a new position in shares of Transcat during the 4th quarter worth approximately $182,000. Finally, US Bancorp DE boosted its stake in shares of Transcat by 15.6% during the 3rd quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company's stock worth $187,000 after acquiring an additional 209 shares during the period. 98.34% of the stock is currently owned by institutional investors.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.